02-04-2015, 01:09 PM
(02-04-2015, 12:47 PM)Kerim Wrote: What do you all make of the substantial drop today on news of discounting their Hep C products?
Bigger than expected discounting of HCV products, or "the price war is real" as Merrill puts it. Also a growing percentage of public vs. private payers, which pay less. In other words, the bear case is growing stronger.
Still, it remains a deep value stock and the multiple is compressing. S&P just raised their price target to $143.